Colony Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Colony Group’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-735	Closed	-$44K	–	771
2023 Q1	$44K	Hold	735	–	–	﹤0.01%	775
2022 Q4	$68K	Hold	735	–	–	﹤0.01%	817
2022 Q3	$88K	Hold	735	–	–	﹤0.01%	752
2022 Q2	$57K	Hold	735	–	–	﹤0.01%	805
2022 Q1	$114K	Hold	735	–	–	﹤0.01%	824
2021 Q4	$177K	Hold	735	–	–	﹤0.01%	780
2021 Q3	$316K	Hold	735	–	–	0.01%	672
2021 Q2	$401K	Hold	735	–	–	0.01%	580
2021 Q1	$287K	Hold	735	–	–	0.01%	651
2020 Q4	$315K	Hold	735	–	–	0.01%	601
2020 Q3	$626K	Hold	735	–	–	0.02%	435
2020 Q2	$608K	Hold	735	–	–	0.02%	423
2020 Q1	$273K	Hold	735	–	–	0.01%	568
2019 Q4	$280K	Buy	+735	New	+$68.6K	0.01%	651

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Colony Group's KRSA Position: Q2 2023 in Review

Colony Group sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 735 shares — an estimated $44K sold.

Colony Group first reported a position in KRSA in Q4 2019 and held it in 14 quarters. The position peaked at $626K in Q3 2020. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

Colony Group reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Colony Group sold 735 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $44K.
Colony Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
Colony Group's Korsana Biosciences, Inc. Common Stock position peaked at $626K in Q3 2020.
17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Colony Group's 13F filing for Q2 2023, filed 15 Aug 2023.